Zota Health Care LImited — Board Meeting, 04-02-2026: Outcome of Board Meeting
04-02-2026 | 07:10 pm
04-02-2026 | 07:10 pm
Zota Health Care's board approved Q3 financial results, reporting a consolidated loss of ₹29.64 Cr on ₹142.95 Cr revenue. Key decisions include acquiring 58,827 shares of Davaindia Health Mart (₹25.30 Cr) and 100% of Curexis Ventures (₹0.10 Cr) to expand retail pharmacy, plus constituting a Risk Management Committee.
No comments yet. Be the first to comment!
